Howard Capital Management »

Taysha Gene Therapies shares owned by Howard Capital Management

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Howard Capital Management from 13F filings

Historical chart of Howard Capital Management investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Howard Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $41k 14k 2.87
2023-12-31 $25k 14k 1.77

More positions owned by Howard Capital Management

Northern Lts Fd Tr Iii Hcm Defnd 100 (QQH)
Northern Lts Fd Tr Iii Hcm Defen 500 (LGH)
Direxion Shs Etf Tr Direxion Hcm (HCMT)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Ishares Tr Core Us Aggbd Et (AGG)
Proshares Tr Ultrapro Qqq (TQQQ)
Vanguard Index Fds Growth Etf (VUG)
Broadcom (AVGO)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr S&p 500 Grwt Etf (IVW)
Wisdomtree Tr Floatng Rat Trea (USFR)
Ishares Tr Russell 2000 Etf (IWM)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Proshares Tr Pshs Ultra Qqq (QLD)

View all positions for Howard Capital Management

Top funds holding Taysha Gene Therapies

RA Capital Management
VR Adviser
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Artal Group
Millennium Management
Point72 Asset Management
Citadel Advisors
Damian Sousa
Cowen And Company
Susquehanna International
T. Rowe Price Associates
Schonfeld Strategic Advisors
Quantum Private Wealth

View all funds holding Taysha Gene Therapies